These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17122357)

  • 1. Emerging therapeutic strategies for obesity.
    Foster-Schubert KE; Cummings DE
    Endocr Rev; 2006 Dec; 27(7):779-93. PubMed ID: 17122357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and investigational antiobesity agents and obesity therapeutic treatment targets.
    Bays HE
    Obes Res; 2004 Aug; 12(8):1197-211. PubMed ID: 15340100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigational therapies in the treatment of obesity.
    Mancini MC; Halpern A
    Expert Opin Investig Drugs; 2006 Aug; 15(8):897-915. PubMed ID: 16859393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New targets for obesity pharmacotherapy.
    Aronne LJ; Thornton-Jones ZD
    Clin Pharmacol Ther; 2007 May; 81(5):748-52. PubMed ID: 17438540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The regulation of body mass and its relation to the development of obesity].
    Juhász A; Katona E; Csongrádi E; Paragh G
    Orv Hetil; 2007 Sep; 148(39):1827-36. PubMed ID: 17890170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity pharmacotherapy: current perspectives and future directions.
    Misra M
    Curr Cardiol Rev; 2013 Feb; 9(1):33-54. PubMed ID: 23092275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs for obesity therapy.
    Zanella MT; Ribeiro Filho FF
    Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):271-80. PubMed ID: 19466220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minireview: Endocannabinoids and their receptors as targets for obesity therapy.
    de Kloet AD; Woods SC
    Endocrinology; 2009 Jun; 150(6):2531-6. PubMed ID: 19372200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Obesity: a review of currently used antiobesity drugs and new compounds in clinical development].
    Zieba R
    Postepy Hig Med Dosw (Online); 2007 Oct; 61():612-26. PubMed ID: 17971763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine control of food intake.
    Valassi E; Scacchi M; Cavagnini F
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of leptin and hypothalamic neuropeptides in energy homeostasis: update on leptin in obesity.
    Mantzoros CS
    Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S85-9. PubMed ID: 11527094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neuropeptides and leptin on nutrient partitioning: dysregulations in obesity.
    Jeanrenaud B; Rohner-Jeanrenaud F
    Annu Rev Med; 2001; 52():339-51. PubMed ID: 11160783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man.
    Hallschmid M; Benedict C; Born J; Fehm HL; Kern W
    Physiol Behav; 2004 Oct; 83(1):55-64. PubMed ID: 15501491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine regulation of food intake.
    Chaptini L; Peikin S
    Curr Opin Gastroenterol; 2008 Mar; 24(2):223-9. PubMed ID: 18301275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut peptides in the regulation of food intake and energy homeostasis.
    Murphy KG; Dhillo WS; Bloom SR
    Endocr Rev; 2006 Dec; 27(7):719-27. PubMed ID: 17077190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ.
    Inui A; Asakawa A; Bowers CY; Mantovani G; Laviano A; Meguid MM; Fujimiya M
    FASEB J; 2004 Mar; 18(3):439-56. PubMed ID: 15003990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance.
    Bermudez-Silva FJ; Cardinal P; Cota D
    J Psychopharmacol; 2012 Jan; 26(1):114-24. PubMed ID: 21824982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine and the regulation of body weight.
    Jørgensen EA; Knigge U; Warberg J; Kjaer A
    Neuroendocrinology; 2007; 86(3):210-4. PubMed ID: 17848791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of central leptin resistance in obesity.
    Jung CH; Kim MS
    Arch Pharm Res; 2013 Feb; 36(2):201-7. PubMed ID: 23359004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights on the role of the endocannabinoid system in the regulation of energy balance.
    Gatta-Cherifi B; Cota D
    Int J Obes (Lond); 2016 Feb; 40(2):210-9. PubMed ID: 26374449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.